Scientific Reports
July 2, 2021
Carrie Cuttler, Emily M LaFrance, Amanda Stueber
Statewide legislation has increased public access to high-potency cannabis flower and concentrates, yet federal restrictions limit researchers' access to relatively low-potency whole-plant cannabis. The goal of this study was to examine the acute effects of high-potency cannabis on cognition using a novel methodology. We further sought to compare cognitive effects of high-potency cannabis...
March 1, 2021
Benjamin J. Warnick, Alexander S. Kier, Emily M LaFrance et al.
Abstract New venture ideation is critical to the entrepreneurial process. To generate creative ideas, some entrepreneurs turn to cannabis, proposing its benefits. However, extant research has not validated such claims. Using a new venture ideation task, we explore differences between cannabis users' and non-users' creativity in new venture ideation by assessing the originality and feasibility...
Journal of Affective Disorders
January 15, 2021
Dakota Mauzay, Emily M LaFrance, Carrie Cuttler
Little is known about the the acute effects of cannabis on symptoms of OCD in humans. Therefore, this study sought to: 1) examine whether symptoms of OCD are significantly reduced after inhaling cannabis, 2) examine predictors (gender, dose, cannabis constituents, time) of these symptom changes and 3) explore potential long-term consequences of repeatedly using cannabis to self-medicate for OCD...
Journal of Affective Disorders
September 1, 2020
Emily M LaFrance, Nicholas C. Glodosky, Marcel O Bonn-Miller et al.
Many individuals use cannabis to manage symptoms of post-traumatic stress disorder (PTSD), and evidence indicates that the endocannabinoid system represents a viable target for treating these symptoms. Data from 404 medical cannabis users who self-identified as having PTSD were obtained from Strainprint®, a medical cannabis app that patients use to track changes in symptoms as a function of...